Sage Therapeutics Stock (NASDAQ: SAGE) stock price, news, charts, stock research, profile.
Open | $10.94 |
Close | $10.62 |
Volume / Avg. | 324.28K / 1.30M |
Day Range | 10.60 - 11.00 |
52 Wk Range | 9.76 - 49.74 |
Market Cap | $639.09M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 14.71% |
Days to Cover | 5.37 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Sage Therapeutics (NASDAQ:SAGE) through any online brokerage.
Other companies in Sage Therapeutics’s space includes: Immunome (NASDAQ:IMNM), 89bio (NASDAQ:ETNB), Humacyte (NASDAQ:HUMA), Mesoblast (NASDAQ:MESO) and AnaptysBio (NASDAQ:ANAB).
There is no analysis for Sage Therapeutics.
Sage Therapeutics has a consensus price target of $22.88.
The stock price for Sage Therapeutics (NASDAQ: SAGE) is $10.6192 last updated July 3, 2024 at 1:12 PM EDT.
There are no upcoming dividends for Sage Therapeutics.
Sage Therapeutics’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for Sage Therapeutics.
Sage Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.